The Food and Drug Administration has officially accepted a gene therapy application for Huntington’s disease, scheduling a final regulatory decision for early 2027 alongside a tentative advisory committee review. Concurrently, a cross-border fertility market has developed around mitochondrial replacement therapy, drawing older women into costly procedures despite scarce efficacy data. Recent animal studies also revealed that the long-term clinical benefits of psilocybin remain difficult to replicate in mouse models.
Key points
An advisory committee meeting is tentatively planned by the agency to review data on AMT-…: An advisory committee meeting is tentatively planned by the agency to review data on AMT-130.
An eight-month investigation revealed a medical tourism trade marketing three-parent IVF…: An eight-month investigation revealed a medical tourism trade marketing three-parent IVF as a biological clock reversal.
Experimental research indicates that the enduring therapeutic benefits associated with ps…: Experimental research indicates that the enduring therapeutic benefits associated with psilocybin remain elusive in mice.
Sources checked by our analysis pipeline: 1
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Wishing you a colorful Día de los Muertos. Remembering my grandmother, in particular, a zoology professor who sparked my penchant for all things biological. Her dissertation was on shrimp chromatophores, I believe.
The need-to-know this morning
- UniQure said the Food and Drug Administration accepted the marketing application for its AMT-130 gene therapy to treat Huntington’s disease. The approval decision date is May 1, 2027. The FDA is “tentatively planning” an advisory committee meeting to review the AMT-130 data, the company said.
Scant evidence for a next-gen, destination IVF business
A fertility treatment framed as a way to rewind the biological clock has spawned an international medical tourism business — with precious little evidence to back it up. An eight-month STAT investigation found clinics and middlemen marketing mitochondrial replacement, or “three-parent IVF,” to older women willing to spend tens of thousands of dollars for a shot at a genetically related child.
Millions of Americans heading to the polls are letting persistent medical expenses dictate their electoral decisions. The midterm cycle functions as an explicit referendum on the financial strains experienced by workers receiving employer-sponsored health insurance coverage. Contested industry practices, such as classifying urgent care treatments as more expensive emergency room visits, further aggravate these ongoing pocketbook frustrations.
Spanish second-tier forward Jesus de Miguel was rushed to the hospital after taking a direct knee to the chest during a stoppage-time collision. Emergency responders successfully resuscitated the striker following a cardiac arrest inside the ambulance, leaving the athlete unconscious but in stable condition. The late-game medical crisis deeply distressed players and halted the fixture in its final minutes.
Critical deficits of fuel, medicine, and food are forcing medical facilities to resort to makeshift treatments and ration life-saving care. The collapse in utility services follows intensified Washington sanctions and the loss of subsidized fuel shipments from Venezuela, creating an unprecedented public health disaster. Consequently, medical teams are struggling to keep basic diagnostic and surgical operations functional amid chronic rolling blackouts.